Medical Marijuana and Hemp News
Medical Marijuana and Hemp News
Medical Marijuana In Nebraska: Third Time Lucky?
Nebraskans for Medical Marijuana (NMM) has formally kicked off its signature collection drive to put the legalization of medical cannabis before Nebraskan voters in November 2024.This is the third time NMM has attempted to get the issue on the ballot. While its campaign collected more than enough signatures in...
Republicans Rail Against Marijuana Rescheduling Recommendation
In the USA, more than a dozen Republican lawmakers have put their name to a letter urging the Drug Enforcement Administration to maintain marijuana's Schedule I status.Schedule I status is reserved for substances with a high potential for abuse, no currently accepted medical use, and a lack of accepted...
Pennsylvania Podiatrists Could Be Prescribing Cannabis Soon
A recent meeting of Pennsylvania's Medical Marijuana Board gave a green light for podiatrist prescribers, but its red light will remain for edibles.One of the items on the Board's September 6 meeting was discussion and consideration of a recommendation to add podiatrists to the list of practitioners who can...
Preliminary QUEST Initiative Study Results Released
A major Australian multicenter study has indicated medicinal cannabis is providing health related quality of life (HRQL) and other benefits for patients.The Australian Government backed QUEST* Initiative involved 2762 participants who had been prescribed medicinal cannabis between November 2020 and December 2021 across six Australian states. As well...
Study: Cannabis Use Among US Cancer Patients Common
Another study has revealed cannabis use is prevalent among cancer patients in the USA - but often their oncologists don't know.In this latest study, patients with various types of cancers residing in states where medical cannabis is legal and who were being treated at Memorial Sloan Kettering Cancer Center...
Bod Unveils Initial Schedule 3 CBD Candidate Trial Results
Australian medical cannabis company Bod Science Limited (ASX:BOD) has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3 CBD (cannabidiol) product for the local market.In late 2020, Australia's Therapeutic Goods Administration (TGA) announced it would down-schedule certain cannabidiol (CBD) preparations to Schedule 3...
Australia’s Cannatrek Awarded GMP Accreditation For Victorian Facility
Medical cannabis company Cannatrek has been successful in securing Good Manufacturing Practice (GMP) accreditation for its Shepparton facility in regional Victoria.The $5 million manufacturing facility, which has received support from the Victorian Government, is part of a planned $17 million investment by Cannatrek into the region that incorporates cultivation...
2023 Global Hemp Summit Nears
Those wanting to attend the 2023 Global Hemp Manufacturing and Commercialisation Summit being held in Melbourne, Australia late this month only have a couple of days left to register.Hosted by the University of Melbourne, this year's event will be held Wednesday 27th - Thursday 28th of September at Graduate...
Pesticide Levels High In Illicit Canadian Cannabis
A Health Canada study has indicated a huge difference in pesticide prevalence between regulated and illicit cannabis.Medicinal cannabis has been legal in Canada since 2001 and was legalised for recreational use in 2018. Among the requirements for licensed producers is no unauthorized pesticides are used to treat cannabis or...
HHS Weighs In On Marijuana Scheduling
The USA's Department of Health and Human Services (HHS) has submitted its scheduling recommendation for marijuana to the Drug Enforcement Agency.While hemp is legal in the USA at a federal level, marijuana is still illegal and is listed as a Schedule I substance under the US Controlled Substances Act...

